Recent news on Multihance

FDA Requests Boxed Warning for Contrast Agents Used to Improve MRI  -  25 May 2007
NewsBlaze,NSF also has developed after the sequential administration of Omniscan and MultiHance and Omniscan and ProHance. Because reports incompletely describe

Boxed Warning Requested for Gadolinium-Based Contrast Agents  -  May 24, 2007
Facts and Comparisons,Gadolinium-based contrast agents are used to enhance the quality of magnetic resonance imaging, with Magnevist, Omniscan, OptiMARK, MultiHance, and ProHance

FDA Orders Black Box Warning for Gadolinium-Based Contrast Agents  -  May 23, 2007
MedPage Today,Those products are gadopentetate dimeglumine (Magnevist), gadodiamide (Ominiscan), gadoversetamide (OptiMARK), gadobenate dimeglumine (MultiHance),

Diagnostic danger  -  Mar 13, 2007
Canoe.ca,The seven gadolinium-containing contrast agents sold in Canada are Omniscan, Magnevist, Optimark, Gadovist, ProHance, MultiHance and Vasovist.

MRI agents, skin disease linked  -  Mar 14, 2007
London Free Press,The gadolinium-containing contrast agents authorized for sale in Canada are Omniscan, Magnevist, Optimark, Gadovist, ProHance, MultiHance and Vasovist.

FDA Issues Advisory for Gadolinium-based Contrast Agents  -  Jan 2, 2007
Facts and Comparisons,...or feet; pain deep in the hip bones or ribs; and muscle weakness. Gadolinium-based agents include Magnevist, MultiHance, Omniscan, OptiMARK, and ProHance.

FDA Issues Alert on Gadolinium-Based Contrast Agent for Kidney ...  -  Dec 22, 2006
MedPage Today,There are five FDA-approved gadolinium-based contrast agents, Magnevist, MultiHance, Omniscan, OptiMARK, and ProHance. These contrast agents are FDA

MRI Contrast Agents May Pose Risk for Patients With Kidney Disease  -  Jan 16, 2007
Journal of American Medical Association (subscription),So far, no cases have been reported with patients taking gadoteridol (ProHance) or gadobenate dimeglumine (MultiHance). Kanal does not know if absence of

Use of Gadolinium in MRI and MRA Linked to NSF/NFD in Patients With...  -  Jan 2, 2007
Medscape (subscription)OptiMARK, Magnevist, ProHance [made by Bracco Diagnostics, Inc], and MultiHance [made by Bracco Diagnostics, Inc]) are approved for use in MRA.

FDA Issues Alert on Gadolinium-Based Contrast Agent for Kidney ...  -  Dec 22, 2006
MedPage Today,There are five FDA-approved gadolinium-based contrast agents, Magnevist, MultiHance, Omniscan, OptiMARK, and ProHance. These contrast agents are FDA

Portal Vein Thrombosis May Alter the Correct Evaluation of ...  -  Nov 22, 2006
Journal of Ultrasound in Medicine (subscription)...the T2-weighted scan (Figure 2A ); after delivery of a contrast agent bolus (0.5-mol/L gadobenate dimeglumine solution; MultiHance; Bracco SpA, Milan,

Results from the Largest Ever CNS MR Crossover Investigation ...  Aug 1, 2006
Intraindividual Crossover Comparative Study of Two MR Contrast Agents" the authors conclude: "The findings in our study indicate that MultiHance(R)(gadobenate ... -Business Wire

Amerinet and Bracco Diagnostics Inc. Sign Three-Year Agreement on ...  Jan 26, 2006
This customized contract includes Isovue(R) (iopamidol injection); MultiHance(R) (gadobenate dimeglumine) injection, 529 mg/mL; ProHance(R) (gadoteridol ... - Business Wire

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional